CSL to bring ‘next-generation’ mRNA flu vaccines to Australia
Australia’s biotech manufacturing giant, CSL, has signed a new $313 million deal to bring “next-generation” mRNA flu shots to our shores.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed